M. Sharon Stack
Chemistry and Biochemistry
Ann F. Dunne and Elizabeth Riley Director, Harper Cancer Research Institute;
Professor, Chemistry & Biochemistry
- Tumor metastasis
- Ovarian cancer
- Oral cancer
- Cell and molecular biology
Stack’s 91视频
Stack in the News
Bioengineer.org
May 28, 2026
Jun Li, the corresponding author and a professor in the Department of Applied and Computational Mathematics and Statistics at Notre Dame, emphasized the significance of this void in cancer research.
Sharon Stack, Kleiderer-Pezold Professor of Biochemistry and Director of the Harper Cancer Research Institute, highlighted the impetus behind this research thrust.
The Scientist Magazine
Audio
May 08, 2024
As an undergraduate student at Clemson University, Sharon Stack became fascinated with the study of the chemical processes and molecular interactions that take place inside living cells.
Galway Advertiser
September 01, 2023
Cancer researchers at University of Galway and Notre Dame’s Harper Cancer Research Institute have come together to establish the Biseach Initiative, a strategic cancer research collaboration, which aims to build on the ideas, talent and infrastructure of both universities for global cancer impact.
Silicon Republic
August 30, 2023
The collaboration will see University of Galway and University of Notre Dame work together on cancer research and strengthen links between both institutions.
Galway Bay
August 29, 2023
Professor M. Sharon Stack, Director of the University of Notre Dame Harper Cancer Research Institute, and Professor Michael Kerin, Director of the Saolta-University of Galway Cancer Centre, signed the agreement
WVPE
August 03, 2023
In a study published this month in the Journal of Experimental & Clinical Cancer Research, University of Notre Dame researchers in collaboration with NeoGenomics Laboratories have shed new light on one key factor that can make ovarian cancer especially deadly: obesity.
July 20, 2023
In a study published this month in the Journal of Experimental & Clinical Cancer Research, University of Notre Dame researchers in collaboration with NeoGenomics Laboratories have shed new light on one key factor that can make ovarian cancer especially deadly: obesity.